Beta-Adrenergic Blockade and Voice: A Double-Blind, Placebo-Controlled Trial

Cheryl L. Giddens, Kirk W. Barron, Keith F. Clark, William D. Warde

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

This study investigated the effects of laboratory-induced stress and beta-adrenergic blockade on acoustic and aerodynamic voice measures. In a double-blind, placebo-controlled trial, 12 participants, six males and six females, underwent cold pressor-induced sympathetic activation followed by placebo or treatment with 40 mg propranolol. Aerodynamic and acoustic parameters of voice were collected at baseline, during cold pressor and after treatment with propranolol or placebo. Fundamental frequency, jitter, shimmer, maximum airflow declination rate, voice onset time, speaking rate, and subglottal pressure were measured at baseline, during cold pressor-induced stress, and after treatment with propranolol or placebo. Cardiovascular measures served as indicators of sympathetic nervous system (SNS) activation by cold pressor and antagonism by propranolol, and were collected during all conditions. Cold pressor appeared to adequately agonize the SNS as indicated by significant increases in resting systolic and diastolic blood pressure and heart rate. Propranolol appeared to adequately antagonize the SNS for the participants. Jitter ratio demonstrated a statistically significant increase in the participants treated with propranolol. Speaking rate demonstrated a small but significant increase in the placebo control group during cold pressor. Gender differences were observed in a few measures. Cold pressor adequately agonized and propranolol adequately antagonized the SNS. No statistically significant differences across subjects were observed in the voice parameters during cold pressor-induced stress before treatment. Jitter ratio increased significantly during propranolol treatment and cold pressor. Speaking rate demonstrated a statistically significant increase during cold pressor in the placebo control group. Gender differences were observed, but were few.

Original languageEnglish
Pages (from-to)477-489
Number of pages13
JournalJournal of Voice
Volume24
Issue number4
DOIs
StatePublished - 1 Jul 2010

Fingerprint

Adrenergic Agents
Propranolol
Placebos
Sympathetic Nervous System
Acoustics
Blood Pressure
Therapeutics
Control Groups
Heart Rate
Pressure

Keywords

  • Acoustic
  • Aerodynamic
  • Autonomic nervous system
  • Beta-adrenergic blockade
  • Fundamental frequency
  • Jitter
  • Maximum airflow declination rate
  • Shimmer
  • Speaking rate
  • Stage fright
  • Stress
  • Subglottal pressure
  • Sympathetic nervous system
  • Voice
  • Voice onset time

Cite this

Giddens, Cheryl L. ; Barron, Kirk W. ; Clark, Keith F. ; Warde, William D. / Beta-Adrenergic Blockade and Voice : A Double-Blind, Placebo-Controlled Trial. In: Journal of Voice. 2010 ; Vol. 24, No. 4. pp. 477-489.
@article{8e15e8a6e4184dc58caed801c798693d,
title = "Beta-Adrenergic Blockade and Voice: A Double-Blind, Placebo-Controlled Trial",
abstract = "This study investigated the effects of laboratory-induced stress and beta-adrenergic blockade on acoustic and aerodynamic voice measures. In a double-blind, placebo-controlled trial, 12 participants, six males and six females, underwent cold pressor-induced sympathetic activation followed by placebo or treatment with 40 mg propranolol. Aerodynamic and acoustic parameters of voice were collected at baseline, during cold pressor and after treatment with propranolol or placebo. Fundamental frequency, jitter, shimmer, maximum airflow declination rate, voice onset time, speaking rate, and subglottal pressure were measured at baseline, during cold pressor-induced stress, and after treatment with propranolol or placebo. Cardiovascular measures served as indicators of sympathetic nervous system (SNS) activation by cold pressor and antagonism by propranolol, and were collected during all conditions. Cold pressor appeared to adequately agonize the SNS as indicated by significant increases in resting systolic and diastolic blood pressure and heart rate. Propranolol appeared to adequately antagonize the SNS for the participants. Jitter ratio demonstrated a statistically significant increase in the participants treated with propranolol. Speaking rate demonstrated a small but significant increase in the placebo control group during cold pressor. Gender differences were observed in a few measures. Cold pressor adequately agonized and propranolol adequately antagonized the SNS. No statistically significant differences across subjects were observed in the voice parameters during cold pressor-induced stress before treatment. Jitter ratio increased significantly during propranolol treatment and cold pressor. Speaking rate demonstrated a statistically significant increase during cold pressor in the placebo control group. Gender differences were observed, but were few.",
keywords = "Acoustic, Aerodynamic, Autonomic nervous system, Beta-adrenergic blockade, Fundamental frequency, Jitter, Maximum airflow declination rate, Shimmer, Speaking rate, Stage fright, Stress, Subglottal pressure, Sympathetic nervous system, Voice, Voice onset time",
author = "Giddens, {Cheryl L.} and Barron, {Kirk W.} and Clark, {Keith F.} and Warde, {William D.}",
year = "2010",
month = "7",
day = "1",
doi = "10.1016/j.jvoice.2008.12.002",
language = "English",
volume = "24",
pages = "477--489",
journal = "Journal of Voice",
issn = "0892-1997",
publisher = "Mosby Inc.",
number = "4",

}

Beta-Adrenergic Blockade and Voice : A Double-Blind, Placebo-Controlled Trial. / Giddens, Cheryl L.; Barron, Kirk W.; Clark, Keith F.; Warde, William D.

In: Journal of Voice, Vol. 24, No. 4, 01.07.2010, p. 477-489.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Beta-Adrenergic Blockade and Voice

T2 - A Double-Blind, Placebo-Controlled Trial

AU - Giddens, Cheryl L.

AU - Barron, Kirk

AU - Clark, Keith F.

AU - Warde, William D.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - This study investigated the effects of laboratory-induced stress and beta-adrenergic blockade on acoustic and aerodynamic voice measures. In a double-blind, placebo-controlled trial, 12 participants, six males and six females, underwent cold pressor-induced sympathetic activation followed by placebo or treatment with 40 mg propranolol. Aerodynamic and acoustic parameters of voice were collected at baseline, during cold pressor and after treatment with propranolol or placebo. Fundamental frequency, jitter, shimmer, maximum airflow declination rate, voice onset time, speaking rate, and subglottal pressure were measured at baseline, during cold pressor-induced stress, and after treatment with propranolol or placebo. Cardiovascular measures served as indicators of sympathetic nervous system (SNS) activation by cold pressor and antagonism by propranolol, and were collected during all conditions. Cold pressor appeared to adequately agonize the SNS as indicated by significant increases in resting systolic and diastolic blood pressure and heart rate. Propranolol appeared to adequately antagonize the SNS for the participants. Jitter ratio demonstrated a statistically significant increase in the participants treated with propranolol. Speaking rate demonstrated a small but significant increase in the placebo control group during cold pressor. Gender differences were observed in a few measures. Cold pressor adequately agonized and propranolol adequately antagonized the SNS. No statistically significant differences across subjects were observed in the voice parameters during cold pressor-induced stress before treatment. Jitter ratio increased significantly during propranolol treatment and cold pressor. Speaking rate demonstrated a statistically significant increase during cold pressor in the placebo control group. Gender differences were observed, but were few.

AB - This study investigated the effects of laboratory-induced stress and beta-adrenergic blockade on acoustic and aerodynamic voice measures. In a double-blind, placebo-controlled trial, 12 participants, six males and six females, underwent cold pressor-induced sympathetic activation followed by placebo or treatment with 40 mg propranolol. Aerodynamic and acoustic parameters of voice were collected at baseline, during cold pressor and after treatment with propranolol or placebo. Fundamental frequency, jitter, shimmer, maximum airflow declination rate, voice onset time, speaking rate, and subglottal pressure were measured at baseline, during cold pressor-induced stress, and after treatment with propranolol or placebo. Cardiovascular measures served as indicators of sympathetic nervous system (SNS) activation by cold pressor and antagonism by propranolol, and were collected during all conditions. Cold pressor appeared to adequately agonize the SNS as indicated by significant increases in resting systolic and diastolic blood pressure and heart rate. Propranolol appeared to adequately antagonize the SNS for the participants. Jitter ratio demonstrated a statistically significant increase in the participants treated with propranolol. Speaking rate demonstrated a small but significant increase in the placebo control group during cold pressor. Gender differences were observed in a few measures. Cold pressor adequately agonized and propranolol adequately antagonized the SNS. No statistically significant differences across subjects were observed in the voice parameters during cold pressor-induced stress before treatment. Jitter ratio increased significantly during propranolol treatment and cold pressor. Speaking rate demonstrated a statistically significant increase during cold pressor in the placebo control group. Gender differences were observed, but were few.

KW - Acoustic

KW - Aerodynamic

KW - Autonomic nervous system

KW - Beta-adrenergic blockade

KW - Fundamental frequency

KW - Jitter

KW - Maximum airflow declination rate

KW - Shimmer

KW - Speaking rate

KW - Stage fright

KW - Stress

KW - Subglottal pressure

KW - Sympathetic nervous system

KW - Voice

KW - Voice onset time

UR - http://www.scopus.com/inward/record.url?scp=77953915183&partnerID=8YFLogxK

U2 - 10.1016/j.jvoice.2008.12.002

DO - 10.1016/j.jvoice.2008.12.002

M3 - Article

C2 - 19846273

AN - SCOPUS:77953915183

VL - 24

SP - 477

EP - 489

JO - Journal of Voice

JF - Journal of Voice

SN - 0892-1997

IS - 4

ER -